Nuevo proyecto en China

by Albian Group

Recientemente Albian Group ha conseguido marcar un nuevo hito en su trayectoria pues nos ha sido encomendado nuestro primer proyecto en China.

Read more

EMA Network strategy to 2025

by Asphalion

The European Medicines Agency Network Strategy to 2025 was detailed just last week during the 20th Regulatory Affairs and Pharmacovigilance conference.

Read more

Curso online: 'Novedades relacionadas con medicamentos en el entorno regulatorio europeo'. 4 y 5 de febrero, 2021

by Asphalion

Nuestros expertos Vicente Tur, Regulatory Affairs Director y Ramón Hernández Moratinos, Senior Regulatory Information Specialist, junto a Ana Viñas, Técnico de la AEMPS serán ponentes en el curso...

Read more

EMA 20th Regulatory Affairs and Pharmacovigilance Conference

by Asphalion

The 20th Regulatory Affairs and Pharmacovigilance conference of Medicines for Europe keeps on providing useful insights of the path ahead.

Read more

BREXIT | What’s new for Pharma and Medical Devices

by Asphalion

Providing guidance about Regulatory Affairs and Trade changes in the Pharma and Medical Devices industries

Read more

GENESIS Biomed is reinforced by hiring a top-level advisory panel

by GENESIS Biomed

​ GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respe...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Descubren los mecanismos de resistencia ...

by Universidad de Navarra

El Cima y la Clínica Universidad de Navarra coordinan este estudio mu...

Photos Stream